|
HBS1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66533453693773E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
2.11909999991988E-07 |
| Normal-vs-Stage3 |
1.755590E-04 |
| Normal-vs-Stage4 |
9.246500E-02 |
| Stage1-vs-Stage2 |
1.924610E-01 |
| Stage1-vs-Stage3 |
1.721910E-02 |
| Stage1-vs-Stage4 |
5.514400E-02 |
| Stage2-vs-Stage3 |
4.627800E-01 |
| Stage2-vs-Stage4 |
3.813800E-01 |
| Stage3-vs-Stage4 |
7.391000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6251444634463E-12 |
| Normal-vs-AfricanAmerican |
4.12309963948587E-10 |
| Normal-vs-Asian |
2.751900E-02 |
| Caucasian-vs-AfricanAmerican |
3.674000E-01 |
| Caucasian-vs-Asian |
8.881800E-01 |
| AfricanAmerican-vs-Asian |
6.668200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.9725000000026E-07 |
| Male-vs-Female |
7.755100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.79439995774101E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.18170000451556E-08 |
| Normal-vs-Extreme_Obese |
4.240700E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.439700E-02 |
| Normal_Weight-vs-Obese |
3.896400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.945800E-01 |
| Extreme_Weight-vs-Obese |
1.403630E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.101600E-01 |
| Obese-vs-Extreme_Obese |
6.038400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.498900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.08622008557313E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.75189887438887E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.808800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.706300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.822300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.099700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.531900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.228200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.00329999863646E-09 |
| Normal-VS-KIRP CIMP |
5.913400E-01 |
| Normal-VS-Unclassified PRCC |
2.7185999995627E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.110000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.8308599999961E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.218500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.471660E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.132000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.060020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63158375698913E-12 |
| Normal-vs-N1 |
5.737700E-02 |
| Normal-vs-N2 |
1.80650000003446E-06 |
| N0-vs-N1 |
9.97839999999917E-05 |
| N0-vs-N2 |
7.101600E-01 |
| N1-vs-N2 |
6.446100E-02 |
|
|
